QT Imaging (NASDAQ:QTI – Get Free Report) and ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation.
Volatility & Risk
QT Imaging has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.
Institutional and Insider Ownership
24.2% of QT Imaging shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 75.4% of QT Imaging shares are held by insiders. Comparatively, 0.7% of ENDRA Life Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QT Imaging | 0 | 0 | 0 | 0 | N/A |
| ENDRA Life Sciences | 0 | 0 | 1 | 0 | 3.00 |
ENDRA Life Sciences has a consensus target price of $8.00, indicating a potential upside of 8,520.69%. Given ENDRA Life Sciences’ higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than QT Imaging.
Valuation and Earnings
This table compares QT Imaging and ENDRA Life Sciences’ gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QT Imaging | N/A | N/A | -$4.03 million | N/A | N/A |
| ENDRA Life Sciences | N/A | N/A | -$10.06 million | ($1.26) | -0.07 |
Profitability
This table compares QT Imaging and ENDRA Life Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QT Imaging | N/A | N/A | -19.75% |
| ENDRA Life Sciences | N/A | -204.78% | -153.48% |
Summary
QT Imaging beats ENDRA Life Sciences on 5 of the 8 factors compared between the two stocks.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
About ENDRA Life Sciences
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
